Dr. Albert D. Min, MD
Hepatology (Hepatology Physician)
- Medicare participating
At a glance
- Medical school
- University of Rochester School of Medicine and Dentistry (1985)
- Years since graduation
- 41
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 313
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1985Medical school: University of Rochester School of Medicine and Dentistry
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hepatology Physician primary
NY license 170352 -
Gastroenterology Physician
NY license 170352
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Englewood Hospital and Medical Center Englewood, NJ
- Mount Sinai Beth Israel New York, NY
Medical groups
- Icahn School of Medicine at Mount Sinai (2,843 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 313
- Services billed
- 782
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 376 | 210 |
| Measurement of liver stiffness | 204 | 182 |
| Established patient office or other outpatient visit, 30-39 minutes | 69 | 67 |
| New patient office or other outpatient visit, 45-59 minutes | 41 | 41 |
| New patient office or other outpatient visit, 60-74 minutes | 23 | 23 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Vemlidy (tenofovir alafenamide) | 139 |
| Entecavir | 60 |
| Ursodiol Other prescribers in New York, NY | 55 |
| Lactulose Other prescribers in New York, NY | 42 |
| Famotidine Other prescribers in New York, NY | 39 |
| Pantoprazole Sodium Other prescribers in New York, NY | 39 |
| Gavilyte-G (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in New York, NY | 28 |
| Omeprazole Other prescribers in New York, NY | 25 |
| Xifaxan (rifaximin) Other prescribers in New York, NY | 23 |
| Enulose (lactulose) Other prescribers in New York, NY | 19 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 86 payments worth $59,086 in total to this clinician.
| Madrigal Pharmaceuticals | $32,641 |
|---|---|
| Gilead Sciences, Inc. | $23,216 |
| GlaxoSmithKline, LLC. | $3,200 |
| AbbVie Inc. | $29.04 |
| Compensation for services other than consulting (speaking, faculty) | $47,556 |
|---|---|
| Travel and Lodging | $4,586 |
| Consulting Fee | $4,258 |
| Food and Beverage | $2,687 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Madrigal Pharmaceuticals Jul 18, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $5,288 |
| Madrigal Pharmaceuticals Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Madrigal Pharmaceuticals Nov 18, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Madrigal Pharmaceuticals Dec 16, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Madrigal Pharmaceuticals Feb 20, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Madrigal Pharmaceuticals May 15, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Madrigal Pharmaceuticals Jun 12, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Gilead Sciences, Inc. Jan 30, 2025 | Compensation for services other than consulting (speaking, faculty) Epclusa · HCV Company’s description;4112388;AHM;10065918 | $3,790 |
| Gilead Sciences, Inc. Apr 25, 2025 | Compensation for services other than consulting (speaking, faculty) Vemlidy · HBV Company’s description;4128272;AHM;10065918 | $3,790 |
| Gilead Sciences, Inc. Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) Epclusa · HCV Company’s description;4180624;AHM;10065918 | $3,790 |
All 31 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Madrigal Pharmaceuticals Dec 16, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Madrigal Pharmaceuticals Dec 16, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to FLUSHING, NY | $239 |
| Madrigal Pharmaceuticals Dec 15, 2025 | Consulting Fee | $1,058 |
| GlaxoSmithKline, LLC. Nov 24, 2025 | Consulting Fee | $3,200 |
| Madrigal Pharmaceuticals Nov 18, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Madrigal Pharmaceuticals Nov 18, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to QUEENS, NY | $254 |
| Gilead Sciences, Inc. Oct 24, 2025 | Compensation for services other than consulting (speaking, faculty) Epclusa · HCV Company’s description;4249460;GTF;10065918 | $600 |
| Gilead Sciences, Inc. Oct 10, 2025 | Compensation for services other than consulting (speaking, faculty) Vemlidy · HBV Company’s description;4265375;AHM;10065918 | $3,790 |
| Gilead Sciences, Inc. Oct 10, 2025 | Travel and Lodging Vemlidy · HBV · travel to New York, NY · in-kind Company’s description;4327621;AHM;10065918 | $508 |
| Madrigal Pharmaceuticals Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Gilead Sciences, Inc. Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) Epclusa · HCV Company’s description;4180624;AHM;10065918 | $3,790 |
| Gilead Sciences, Inc. Aug 14, 2025 | Travel and Lodging Epclusa · HCV · travel to New York, NY · in-kind Company’s description;4327856;AHM;10065918 | $486 |
| Madrigal Pharmaceuticals Jul 18, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $5,288 |
| Madrigal Pharmaceuticals Jul 18, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to DALLAS, TX · in-kind | $305 |
| Madrigal Pharmaceuticals Jul 18, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to DALLAS, TX · in-kind | $244 |
| Madrigal Pharmaceuticals Jul 18, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to DALLAS, TX · in-kind | $103 |
| Madrigal Pharmaceuticals Jun 12, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Madrigal Pharmaceuticals Jun 12, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to FLUSHING, NY | $204 |
| Madrigal Pharmaceuticals May 15, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Gilead Sciences, Inc. May 9, 2025 | Travel and Lodging Epclusa · HCV · travel to Atlanta, GA Company’s description;4027207;GTF;10065918 | $107 |
| Gilead Sciences, Inc. May 9, 2025 | Travel and Lodging Epclusa · HCV · travel to Atlanta, GA Company’s description;4027063;GTF;10065918 | $65.00 |
| Gilead Sciences, Inc. Apr 25, 2025 | Compensation for services other than consulting (speaking, faculty) Vemlidy · HBV Company’s description;4128272;AHM;10065918 | $3,790 |
| Gilead Sciences, Inc. Apr 25, 2025 | Travel and Lodging Vemlidy · HBV · travel to New York, NY · in-kind Company’s description;4327830;AHM;10065918 | $441 |
| Gilead Sciences, Inc. Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) Epclusa · HCV Company’s description;3978785;GTF;10065918 | $3,240 |
| Gilead Sciences, Inc. Mar 1, 2025 | Travel and Lodging Epclusa · HCV · travel to Atlanta, GA · in-kind Company’s description;4026749;GTF;10065918 | $393 |
| Gilead Sciences, Inc. Mar 1, 2025 | Travel and Lodging Epclusa · HCV · travel to Atlanta, GA · in-kind Company’s description;4026744;GTF;10065918 | $350 |
| Gilead Sciences, Inc. Mar 1, 2025 | Travel and Lodging Epclusa · HCV · travel to Atlanta, GA · in-kind Company’s description;4027115;GTF;10065918 | $284 |
| Madrigal Pharmaceuticals Feb 20, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Madrigal Pharmaceuticals Feb 20, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to NEW YORK, NY | $95.07 |
| Gilead Sciences, Inc. Jan 30, 2025 | Compensation for services other than consulting (speaking, faculty) Epclusa · HCV Company’s description;4112388;AHM;10065918 | $3,790 |
| Gilead Sciences, Inc. Jan 24, 2025 | Travel and Lodging Epclusa · HCV · travel to New York, NY · in-kind Company’s description;3956940;AHM;10065918 | $508 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.